John Overdeck’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

John Overdeck’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-64,312	Closed	-$1.2M	–	3144
2022 Q1	$1.2M	Sell	64,312 -148,830	-70%	-$2.68M	﹤0.01%	1623
2021 Q4	$4.56M	Buy	213,142 +171,459	+411%	+$3.38M	0.01%	1250
2021 Q3	$770K	Buy	+41,683	New	+$839K	﹤0.01%	2861
2021 Q2	–	Sell	-210,267	Closed	-$4.06M	–	4756
2021 Q1	$4.06M	Buy	+210,267	New	+$3.7M	0.01%	1188

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

John Overdeck's OCDX Position: Q2 2022 in Review

John Overdeck sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 64,312 shares — an estimated $1.2M sold.

John Overdeck first reported a position in OCDX in Q1 2021 and held it in 4 quarters. The position peaked at $4.56M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

John Overdeck reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
John Overdeck sold 64,312 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1.2M.
John Overdeck first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 4 quarters.
John Overdeck's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $4.56M in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.